Z

Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267

Watchlist Manager
Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Watchlist
Price: 10.56 CNY -0.28%
Market Cap: 12.7B CNY

Wall Street
Price Targets

Price Targets Summary
Zhejiang Hisun Pharmaceutical Co Ltd

Wall Street analysts forecast Zhejiang Hisun Pharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhejiang Hisun Pharmaceutical Co Ltd is 7.65 CNY with a low forecast of 7.58 CNY and a high forecast of 7.88 CNY.

Lowest
Price Target
7.58 CNY
28% Downside
Average
Price Target
7.65 CNY
28% Downside
Highest
Price Target
7.88 CNY
25% Downside
Zhejiang Hisun Pharmaceutical Co Ltd Competitors:
Price Targets
THFF
First Financial Corp
4% Upside

Revenue
Forecast

5% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
5% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 13 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's revenue is 5%. The projected CAGR for the next 3 years is 2%.

Operating Income
Forecast

3% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
3% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 13 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's operating income is 3%. The projected CAGR for the next 3 years is -4%.

Net Income
Forecast

1% / Year
Past Growth
-3% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
1% / Year
Past Growth
-3% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

For the last 13 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's net income is 1%. The projected CAGR for the next 3 years is -3%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang Hisun Pharmaceutical Co Ltd's stock price target?
Price Target
7.65 CNY

According to Wall Street analysts, the average 1-year price target for Zhejiang Hisun Pharmaceutical Co Ltd is 7.65 CNY with a low forecast of 7.58 CNY and a high forecast of 7.88 CNY.

What is Zhejiang Hisun Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
2%

For the last 13 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's revenue is 5%. The projected CAGR for the next 3 years is 2%.

What is Zhejiang Hisun Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-4%

For the last 13 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's operating income is 3%. The projected CAGR for the next 3 years is -4%.

What is Zhejiang Hisun Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-3%

For the last 13 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's net income is 1%. The projected CAGR for the next 3 years is -3%.

Back to Top